Skip to content
10-Q

Quarterly Report

NEMAURA MEDICAL INC.

0001079973-23-001557

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Nov 9, 2023 28.9M sh
Shares Diluted Q2 2024 · Sep 30, 2023 28.9M sh
Shares Diluted Q2 2024 · Sep 30, 2023 28.9M sh
Shares Diluted Q2 2024 · Sep 30, 2022 24.1M sh
Shares Diluted Q2 2024 · Sep 30, 2022 24.1M sh
Capex Q2 2024 · Sep 30, 2023 $66.38K
Operating Cash Flow Q2 2024 · Sep 30, 2023 −$5.72M
Long Term Debt Q2 2024 · Sep 30, 2023 $3.36M
Long Term Debt Q2 2024 · Mar 31, 2023 $3.09M
Short Term Debt Q2 2024 · Sep 30, 2023 $17.55M
Short Term Debt Q2 2024 · Mar 31, 2023 $16.94M
Cash And Equivalents Q2 2024 · Sep 30, 2023 $1.38M
Cash And Equivalents Q2 2024 · Mar 31, 2023 $10.11M
Stockholders Equity Q2 2024 · Sep 30, 2023 −$15.87M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$14.38M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$11.81M
Current Liabilities Q2 2024 · Sep 30, 2023 $21.43M
Current Liabilities Q2 2024 · Mar 31, 2023 $22.27M
Total Liabilities Q2 2024 · Sep 30, 2023 $24.79M
Total Liabilities Q2 2024 · Mar 31, 2023 $26.38M
Current Assets Q2 2024 · Sep 30, 2023 $8.06M
Current Assets Q2 2024 · Mar 31, 2023 $13.54M
Total Assets Q2 2024 · Sep 30, 2023 $8.92M
Total Assets Q2 2024 · Mar 31, 2023 $14.56M
Eps Diluted Q2 2024 · Sep 30, 2023 −$0.05
Eps Diluted Q2 2024 · Sep 30, 2023 −$0.14
Eps Diluted Q2 2024 · Sep 30, 2022 −$0.16
Eps Diluted Q2 2024 · Sep 30, 2022 −$0.32
Eps Basic Q2 2024 · Sep 30, 2023 −$0.05
Eps Basic Q2 2024 · Sep 30, 2023 −$0.14
Eps Basic Q2 2024 · Sep 30, 2022 −$0.16
Eps Basic Q2 2024 · Sep 30, 2022 −$0.32
Sga Expense Q2 2024 · Sep 30, 2023 $1.56M
Sga Expense Q2 2024 · Sep 30, 2023 $3.07M
Rd Expense Q2 2024 · Sep 30, 2023 $491.8K
Rd Expense Q2 2024 · Sep 30, 2023 $1.04M
Net Income Q2 2024 · Sep 30, 2023 −$1.2M
Net Income Q2 2024 · Sep 30, 2023 −$3.81M
Operating Income Q2 2024 · Sep 30, 2023 −$2.05M
Operating Income Q2 2024 · Sep 30, 2023 −$4.11M
Gross Profit Q2 2024 · Sep 30, 2023 $0
Gross Profit Q2 2024 · Sep 30, 2023 $0
Cost Of Revenue Q2 2024 · Sep 30, 2023 $0
Cost Of Revenue Q2 2024 · Sep 30, 2023 $0
Cost Of Revenue Q2 2024 · Sep 30, 2022 $72.36K
Cost Of Revenue Q2 2024 · Sep 30, 2022 $72.36K
Revenue Q2 2024 · Sep 30, 2023 $0
Revenue Q2 2024 · Sep 30, 2023 $0